Business
Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
About this update from Algorae Pharmaceuticals Limited
[{"type":"text","content":"Algorae Pharmaceuticals Limited has released a press release. View Attachment","length":261,"tagName":"div"}]